Eur J Clin Invest. 2021 Dec 12;e13727. doi: 10.1111/eci.13727. Epub 2021 Dec 12.

Insulin action in subjects with type 2 diabetes following biliopancreatic diversion.

European journal of clinical investigation

Francesco Papadia, Flavia Carlini, Alice Rubartelli, Micaela Battistini, Renzo Cordera, Gian Franco Adami, Giovanni Camerini

PMID: 34902158 DOI: 10.1111/eci.13727

[No abstract available.]

Keywords: bariatric/metabolic surgery; insulin action; type 2 diabetes

References

1. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017;16:376641-376651. - PubMed
2. Mingrone G, Panunzi S, De Gaetano A, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2021;397(10271):293-304. - PubMed
3. Briatore L, Salani B, Andraghetti G, et al. Beta-cell function improvement after biliopancreatic diversion in subjects with type 2 diabetes and morbid obesity. Obesity (Silver Spring). 2010;18:932-936. - PubMed
4. Jacobsen SH, Olesen SC, Dirksen C, et al. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg. 2012;22:1084-1096. - PubMed
5. Kang B, Yang Y, Lee EY, et al. Triglycerides/glucose index is a useful surrogate marker of insulin resistance among adolescents. Int J Obes. 2017;41:789-792. - PubMed
6. Longo M, Zatterale F, Naderi J, et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci. 2019;20:2358. - PubMed
7. Navarro-González D, Sánchez-Íñigo L, Fernández-Montero A, Pastrana-Delgado J, Martinez JE. TyG index change is more determinant for forecasting type 2 diabetes onset than weight gain. Medicine. 2016;95(19):e3646. - PubMed
8. Meier JJ, Menge BA, Breuer TG, et al. Functional assessment of pancreatic beta-cell area in humans. Diabetes. 2009;58:1595-1603. - PubMed
9. Scopinaro N, Adami GF, Papadia FS, et al. Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35. Ann Surg. 2011;253:699-703. - PubMed
10. Locateli JC, Lopes WA, Simões CF, et al. Triglyceride/glucose index is a reliable alternative marker for insulin resistance in South American overweight and obese children and adolescents. J Pediatr Endocrinol Metab. 2019;32:1163-1170. - PubMed
11. Camerini GB, Papadia FS, Carlini F, Catalano M, Adami GF, Scopinaro N. The long-term impact of biliopancreatic diversion on glycemic control in the severely obese with type 2 diabetes mellitus in relation to preoperative duration of diabetes. Surg Obes Relat Dis. 2016;12:345-349. - PubMed
12. Poitout V, Amyot J, Semache M, Zarrouki B, Hagman D, Fontés G. Glucolipotoxicity of the pancreatic beta cell. Biochim Biophys Acta. 2010;1801:289-298. - PubMed
13. Ellenbroek JH, Töns HAM, Hanegraaf MAJ, et al. Pancreatic α-cell mass in obesity. Diabetes Obes Metab. 2017;19:1810-1813. - PubMed
14. Adami GF, Camerini G, Papadia F, et al. Type 2 Diabetes remission and control in overweight and in mildly obese diabetic patients at long-term follow-up after biliopancreatic diversion. Obes Surg. 2019;29:239-245. - PubMed
15. Mezza T, Cinti F, Cefalo CMA, Pontecorvi A, Kulkarni RN, Giaccari A. β-cell fate in human insulin resistance and type 2 diabetes: A Perspective on islet plasticity. Diabetes. 2019;68:1121-1129. - PubMed

Publication Types

• Journal Article